A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 6, 2011, Pages 416-422

  Muraraiah, Sushma ^a   Rajarathna, Kavitha ^a   Divyasree, Sreedhar ^a   Basavalingu, Deepashri ^a   Jayanthi, C R ^a  

^a Bengaluru Medical College and Research Institute   (India)

Author keywords

Adverse drug reactions; Attitude; Knowledge; Pharmacovigilance; Practices of pharmacovigilance

Indexed keywords

ADVERSE DRUG REACTION (ADRS); ADVERSE DRUG REACTIONS; ATTITUDE; EDUCATIONAL INTERVENTION; HEALTH CARE PROFESSIONALS; KNOWLEDGE; PHARMACOVIGILANCE; QUESTIONNAIRE STUDIES;

HEALTH CARE; HOSPITALS; PHARMACODYNAMICS; SURVEYS;

PEDIATRICS;

ANTICONVULSIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; SULFONAMIDE; VACCINE;

ARTICLE; AWARENESS; DRUG SURVEILLANCE PROGRAM; HEALTH PERSONNEL ATTITUDE; HUMAN; INDIA; NURSE; PEDIATRIC HOSPITAL; PEDIATRICS; POSTGRADUATE STUDENT; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RESIDENT; TERTIARY HEALTH CARE; UNDERGRADUATE STUDENT; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT;

EID: 84864233298     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Vikas Dhikav, Sindhu Singh, KS Anand. Adverse Drug Reaction Monitoring In India. JIACM, 2004; 5 (1), 27-33.
2. Lazarou J, Pomeranz BH, Corey PN. JAMA, 1998, 279, 1200-1205.
3. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Pediatrics, 2002, 110 (5), e53.
4. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Br J Clin Pharmacol, 2001, 52, 77-83.
5. Siddhartha Ghosh, Leelavathy D. Acharya, Padma Guru Madhva Rao, Nidin Mohan Nair, Subish Palaian. Pharmacologyonline, 2007, 1, 49-56.
6. Jennifer Le, Thuy Nguyen, Anandi V. Law, Jane Hodding. Pediatrics, 2006, 118 (2), 555- 562.
7. World Health Organization. Safety of medicines: A guide to detecting and reporting adverse drug reactions. Geneva: 2002. WHO/EDM/QSM/2002.2.
8. Pankaj Gupta, Aaditya Udupa. J. Pharm. Sci. & Res, 2011, 3 (2), 1064-1069
9. P. Subish, M.I Mohamed Izham, P. Mishra. The Internet Journal of Pharmacology. 2008, 6 (1).
10. Kazeem A Oshikoya, Jacob O Awobusuyi. BMC Clinical Pharmacology, 2009, 9,14.
11. Amanda Clarkson, Sharon Conroy, Karissa Burroughs, Imti Choonara. Paediatric and Perinatal Drug Therapy, 2004, 6 (1), 20-23.
12. Carleton B, Lesko A, Milton J, Poole RL. Curr Ther Res 2001, 62, 738-742.
13. Williams D, Feely J. Ir J Med Sci, 1999, 168 (4), 257-61.
14. Peterson RG, Turner C. Paediatr Child Health, 2003, 8, 213-214.
15. Qing, L., Su-min, Z., Hua-ting, C., Shi-ping, F., Xin, Y., Dong, L., Lu-yuan, S., Fan-dian, Z. Chinese Medical Journal, 2004, 117 (6), 856-861.
16. Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B.J. Clin Epidemiol. 2002, 55 (9), 945-50.
17. Figueiras A, Herdeiro M.T, Polónia J Gestal-Otero J.J: JAMA, 2006, 296,1086-1093.
18. Castel J.M, Figueiras A, Pedros C, Laporte J.R, Capella D. Drug Saf, 2003, 26, 1049-1055.